Laboratory Professionals Member Community

 View Only
  • 1.  Hemolysis, Icterus, and Lipemia Interference: New Approaches to Old Foes | clinicallab

    Posted 14 days ago
    https://www.clinicallab.com/hemolysis-icterus-and-lipemia-interference-new-approaches-to-old-foes-26664




    Sent from my Verizon, Samsung Galaxy smartphone



  • 2.  RE: Hemolysis, Icterus, and Lipemia Interference: New Approaches to Old Foes | clinicallab

    Posted 13 days ago

    I believe Cap, in 2014, addressed the confrontational relationship(unavoidable and toxic) the Lab has with our coworkers concerning hemolysis and potential risks, to patients, and overall negative experience.

    I believe Cap released recommendations taking the automatic redraw the Lab endorses and placing it in the doctor's hands. 

    A patient having a stroke, moderate hemolysis, values released with comments stating hemolysis with recommendations, but the decision is solely the doctor's. The doctor may need to establish kidney function for CT. 

    Large hospitals have LIS post comments and release values taking it completely out of tech hands avoiding non-compliance at the bench level. 

    The difference this makes is felt throughout. 

    The pushback can be overwhelming. 

    Derek Hardwick MLT ASCP 



    ------------------------------
    Derek Hardwick Technician (eg MLT, HT, PBT, DPT)
    Irmo SC
    (843)506-2304
    ------------------------------



  • 3.  RE: Hemolysis, Icterus, and Lipemia Interference: New Approaches to Old Foes | clinicallab

    Posted 12 days ago

    Good morning

    Hemolysis, Icterus, and Lipemia are clinical conditions. CBC results have some effect of this condition. Icterus and Lipemia sample, can be corelated with Chemistry results and Clinicians have clear clinical picture.

    Hemolysis could be collection error which can be recollected. Different situation where patient may be going through Microangiopathic process where repeat sample also will be hemolyzed. In this situation Clinician need the H&H. Hemolyzed specimen may have falsely elevated HgB. 1:5 Dilution as per Sysmex does eliminate hemolysis interreference. HCT is helpful, especially in critically low hemoglobin (could be falsely high due to hemolysis) for clinician to decide transfusion.






  • 4.  RE: Hemolysis, Icterus, and Lipemia Interference: New Approaches to Old Foes | clinicallab

    Posted 12 days ago
    Perfect example of maximizing the capabilities of the advanced technology we now have and almost all provide processes and procedures to address almost any clinical sample and patient populations. 

    Question. NICU baby collected in raised bottom tube. Roughly 400 microliters of sample with PLT count of 350. PLT clumping flag, and clumping on slide. Matches previous values besides drop in PLT count. Recollect the sample? Qns . Reject before running? 

    Check it for clot before performing slight consistency difference, resolved with vortex. 

    Still recollect? What if you have 50 NICU babies in level one trauma center. How many times can you redraw, reject, or the Lab prevents recollects due to clumping, and depending on PLT count, greater than 100 allows release of PLT count with comments 






  • 5.  RE: Hemolysis, Icterus, and Lipemia Interference: New Approaches to Old Foes | clinicallab

    Posted 11 days ago
    If vortexing makes the flag resolve, we report the platelet count. No slide is made. If vortexing does not clear the flag, we make a slide. If any clumping is noted on the slide and the plstelet count is below 100, we don't report the platelet count. If clumping (rare, occasional) is noted and the platelet count is above 100, we report the automated count, report the platelet estimate, and report the platelet clumping. If moderate or marked platelet clumping is noted, we don't report the platelet count as we feel the clumping affects the true count. 





  • 6.  RE: Hemolysis, Icterus, and Lipemia Interference: New Approaches to Old Foes | clinicallab

    Posted 10 days ago
    Sent from my iPhone